NPO Enpro Inc shares rise two percent after Q4 2025 EPS beat and nine percent year over year revenue growth GDRX GoodRx Holdings Inc drops 34 today after Q4 2025 EPS narrowly falls short of analyst expectations What Wall Street expects from Clean Energy CLNE this quarter Q1 2026 EPS Tops Views Duke Energy DUK Strategic Valuation Assessment Amid ShortTerm Volatility and LongTerm Growth Prospects OXLCP Oxford Q4 earnings miss EPS 255 trails 2754 forecast by 74 but preferred shares unmoved Theriva Biologics TOVX Comprehensive Review Theriva Biologics posts 346 EPS beat no revenue FOUR Shift4 Payments Inc reports narrow EPS miss robust year over year revenue growth lifts shares slightly today Spain Shooting Raises Concerns Over Public Safety and Local Economy US Annual Consumer Inflation Posts Largest Gain in Three Years as Price Pressures Broaden Reading Scores Remain Below PrePandemic Levels as Math Recovery Widens National Assessment Shows India Bans Sugar Exports Until September 2026 to Stabilize Domestic Prices Amid Production Concerns